Doximity News

Doximity (DOCS) To Report Earnings Tomorrow: Here Is What To Expect

Barchart02:01

8 Out of 12 S&P 500 Healthcare Companies Beat Profit Consensus This Week: Earnings Scorecard

Seeking AlphaMay 12 10:22

Doximity, Inc.'s (NYSE:DOCS) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

With its stock down 12% over the past three months, it is easy to disregard Doximity (NYSE:DOCS). However, stock prices are usually driven by a company's financial performance over the long term, wh

Simply Wall StMay 4 07:59

Global EHealth Market Is Predicted to Exhibit Remarkable Growth by 2030, Predicts DelveInsight | Key Companies in the Market - Athenahealth, Doximity, Epic Systems Corporation, Koninklijke Philips, Medtronic, IBM, Optum, Medhost

New York, USA, April 30, 2024 (GLOBE NEWSWIRE) -- Global eHealth Market is Predicted to Exhibit Remarkable Growth by 2030, Predicts DelveInsight | Key Companies in the Market - Athenahealth, Doximity, Epic Systems

GlobeNewswireApr 30 12:00

Analysts Offer Insights on Healthcare Companies: Koninklijke Philips (PHG), Doximity (DOCS) and R1 RCM (RCM)

TipRanksApr 30 07:11

Doximity's Strong Market Position Amidst Economic Headwinds: A Balanced Hold Recommendation

TipRanksApr 29 06:06

Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024

Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2024 after market

BusinesswireApr 25 15:01

Doximity Raised to Neutral From Underweight by JP Morgan

Doximity Raised to Neutral From Underweight by JP Morgan

Dow JonesApr 25 07:57

Doximity Price Target Announced at $25.00/Share by JP Morgan

Doximity Price Target Announced at $25.00/Share by JP Morgan

Dow JonesApr 25 07:57

Komo: Upgraded the DOCS.US (DOCS.US) rating from reduced holdings to a neutral rating, with a target price of $25.00.

Komo: Upgraded the DOCS.US (DOCS.US) rating from reduced holdings to a neutral rating, with a target price of $25.00.

Zhitong FinanceApr 25 07:50

JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target Is $25

JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25.

MT NewswiresApr 25 06:08

6 Analysts Assess Doximity: What You Need To Know

In the latest quarter, 6 analysts provided ratings for Doximity (NYSE:DOCS), showcasing a mix of bullish and bearish perspectives.Summarizing their recent assessments, the table below illustrates the

BenzingaApr 23 12:01

Doximity Is Maintained at Underweight by Morgan Stanley

Doximity Is Maintained at Underweight by Morgan Stanley

Dow JonesApr 23 11:34

Morgan Stanley Maintains Underweight on Doximity, Maintains $25 Price Target

Morgan Stanley analyst Ricky Goldwasser maintains Doximity (NYSE:DOCS) with a Underweight and maintains $25 price target.

BenzingaApr 23 11:24

Returns On Capital Signal Tricky Times Ahead For Doximity (NYSE:DOCS)

Yahoo FinanceApr 22 08:39

Dr. Martens Dour US Revenue Outlook for the Year Sends Stock of Iconic Bootmaker Plunging

Yahoo FinanceApr 16 10:45

Doximity, Inc. (NYSE:DOCS) Shares Could Be 32% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Doximity is US$37.19 based on 2 Stage Free Cash Flow to Equity Doximity is estimated to be 32% undervalued based on current share price of US$25.42 Analy

Simply Wall StApr 16 05:05

Shares Plunge in Dr Martens as US Business Struggles

Yahoo FinanceApr 16 04:35

British Equities Drop 1%; Dr Martens, Superdry Tumble

Yahoo FinanceApr 16 02:36

Under The Bonnet, Dr. Martens' (LON:DOCS) Returns Look Impressive

Yahoo FinanceApr 14 04:36